| UK guidelines for the management of pituitary apoplexy S Rajasekaran, M Vanderpump, S Baldeweg, W Drake, N Reddy, ... Clinical endocrinology 74 (1), 9-20, 2011 | 446 | 2011 |
| Clustering of insulin resistance with vascular dysfunction and low-grade inflammation in type 2 diabetes A Natali, E Toschi, S Baldeweg, D Ciociaro, S Favilla, L Sacca, ... Diabetes 55 (4), 1133-1140, 2006 | 288 | 2006 |
| Vascular effects of improving metabolic control with metformin or rosiglitazone in type 2 diabetes A Natali, S Baldeweg, E Toschi, B Capaldo, D Barbaro, A Gastaldelli, ... Diabetes care 27 (6), 1349-1357, 2004 | 238 | 2004 |
| Heterogeneous genetic background of the association of pheochromocytoma/paraganglioma and pituitary adenoma: results from a large patient cohort J Dénes, F Swords, E Rattenberry, K Stals, M Owens, T Cranston, ... The Journal of Clinical Endocrinology & Metabolism 100 (3), E531-E541, 2015 | 176 | 2015 |
| Insulin resistance, lipid and fatty acid concentrations in 867 healthy Europeans Baldeweg, Golay, Natali, Balkau, D Prato, Coppack European journal of clinical investigation 30 (1), 45-52, 2000 | 168 | 2000 |
| Endocrinology in the time of COVID-19: Management of adrenal insufficiency W Arlt, SE Baldeweg, SHS Pearce, HL Simpson European Journal of Endocrinology 183 (1), G25-G32, 2020 | 115 | 2020 |
| Dysnatremia is a predictor for morbidity and mortality in hospitalized patients with COVID-19 P Tzoulis, JA Waung, E Bagkeris, Z Hussein, A Biddanda, J Cousins, ... The Journal of Clinical Endocrinology & Metabolism 106 (6), 1637-1648, 2021 | 105 | 2021 |
| A spectrum of behaviour in silent corticotroph pituitary adenomas SE Baldeweg, JR Pollock, M Powell, J Ahlquist British journal of neurosurgery 19 (1), 38-42, 2005 | 103 | 2005 |
| The screening and management of pituitary dysfunction following traumatic brain injury in adults: British Neurotrauma Group guidance CL Tan, SA Alavi, SE Baldeweg, A Belli, A Carson, C Feeney, ... Journal of Neurology, Neurosurgery & Psychiatry 88 (11), 971-981, 2017 | 92 | 2017 |
| SOCIETY FOR ENDOCRINOLOGY CLINICAL GUIDANCE: Inpatient management of cranial diabetes insipidus SE Baldeweg, S Ball, A Brooke, HK Gleeson, MJ Levy, M Prentice, J Wass Endocrine connections 7 (7), G8-G11, 2018 | 62 | 2018 |
| Haematocrit, type 2 diabetes, and endothelium-dependent vasodilatation of resistance vessels A Natali, E Toschi, S Baldeweg, A Casolaro, S Baldi, AM Sironi, JS Yudkin, ... European heart journal 26 (5), 464-471, 2005 | 58 | 2005 |
| Missed opportunities for diabetes prevention: post-pregnancy follow-up of women with gestational diabetes mellitus in England M Pierce, J Modder, I Mortagy, A Springett, H Hughes, S Baldeweg British Journal of General Practice 61 (591), e611-e619, 2011 | 52 | 2011 |
| Pituitary Carcinoma in a Patient with an SDHB Mutation N Tufton, F Roncaroli, I Hadjidemetriou, MN Dang, J Dénes, L Guasti, ... Endocrine Pathology 28, 320-325, 2017 | 51 | 2017 |
| Identification of adrenocorticotropin receptor messenger ribonucleic acid in the human pituitary and its loss of expression in pituitary adenomas DG Morris, B Kola, N Borboli, GA Kaltsas, M Gueorguiev, AM McNicol, ... The Journal of Clinical Endocrinology & Metabolism 88 (12), 6080-6087, 2003 | 49 | 2003 |
| SOCIETY FOR ENDOCRINOLOGY ENDOCRINE EMERGENCY GUIDANCE: Emergency management of pituitary apoplexy in adult patients SE Baldeweg, M Vanderpump, W Drake, N Reddy, A Markey, GT Plant, ... Endocrine connections 5 (5), G12-G15, 2016 | 46 | 2016 |
| Active and silent thyroid-stimulating hormone− expressing pituitary adenomas: presenting symptoms, treatment, outcomes, and recurrence MA Kirkman, Z Jaunmuktane, S Brandner, AA Khan, M Powell, ... World Neurosurgery 82 (6), 1224-1231, 2014 | 46 | 2014 |
| Iatrogenic Cushing’s syndrome due to drug interaction between glucocorticoids and the ritonavir or cobicistat containing HIV therapies ER Elliot, A Theodoraki, LR Jain, NJ Marshall, M Boffito, SE Baldeweg, ... Clinical Medicine 16 (5), 412, 2016 | 43 | 2016 |
| A follow-up study of the prevalence of valvular heart abnormalities in hyperprolactinemic patients treated with cabergoline WM Drake, CE Stiles, JS Bevan, N Karavitaki, PJ Trainer, DA Rees, ... The Journal of Clinical Endocrinology & Metabolism 101 (11), 4189-4194, 2016 | 39 | 2016 |
| Clinical characteristics, risk factors, and outcomes of POEMS syndrome: a longitudinal cohort study S Keddie, D Foldes, F Caimari, SE Baldeweg, J Bomsztyk, OJ Ziff, J Fehmi, ... Neurology 95 (3), e268-e279, 2020 | 38 | 2020 |
| Increased Population Risk of AIP‐Related Acromegaly and Gigantism in Ireland S Radian, Y Diekmann, P Gabrovska, B Holland, L Bradley, H Wallace, ... Human Mutation 38 (1), 78-85, 2017 | 38 | 2017 |
